Lawyers and Settlements
Advertisement
Home Page >> Potential Lawsuit >> Actemra Lawsuit

Actemra Linked to Heart Attacks and Deaths


Santa Clara, CA: A new drug used to treat rheumatoid arthritis (RA), Actemra (tocilizumab), which is made by Roche/Genentech, has been linked to hundreds of patient deaths resulting from heart attacks, strokes, and heart failure.

An investigation conducted by Stat News has shown that Actemra carried no warning labels concerning potential side effects, specifically cardiovascular and pulmonary complications. The investigation, which involved analysing more than 500,000 side effect reports on rheumatoid arthritis drugs, "found clear evidence" that the risk of the side effects such as heart attack or stroke, "were as high or higher for Actemra patients than for patients taking some competing drugs." The difference, according to Stat News, is that unlike other drug used to treat RA, Actemra does not carry a warning label for those side effects.

The Food and Drug Administration has received reports on 1,128 people who died after taking Actemra, and has reviewed its safety several times since it was approved.

Actemra is a humanized interleukin-6 (IL-6) receptor antagonist approved for treatment of adults with moderately to severely active rheumatoid arthritis. It was approved in 2010 and has been prescribed to more than 760,000 patients.



Actemra Legal Help

If you or a loved one has suffered similar damages or injuries, please fill in our form and your complaint will be sent to a lawyer who may evaluate your claim at no cost or obligation.
Last updated on

DANGEROUS DRUGS LEGAL ARTICLES AND INTERVIEWS

Are Actemra Claimants Headed for Multidistrict Litigation?
Are Actemra Claimants Headed for Multidistrict Litigation?
October 13, 2017
Washington, DC Some law firms and at least one organization that finances mass tort litigation seem to think so. But what does it mean for the little guy when big dogs start to circle around the likelihood that Actrema lawsuits will be consolidated into multidistict litigation (MDL)? Is this a good thing or a bad thing for someone who has had a heart attack after being treated with Actemra? Here’s some background for talking to a lawyer about what happened to you [READ MORE]

Actemra: Failure to Warn
Actemra: Failure to Warn
September 22, 2017
Washington, DC: Given the fact that Actemra is marketed without warning of heart failure, stroke, and other serious injuries like its competitors must do, one would think it is the wonder drug for rheumatoid arthritis sufferers. Until research and adverse event reports (AERS) got in the way and showed the med was just as likely to cause serious injuries as competing drugs - and given attorneys are investigating these AERS,  Actemra lawsuits may be on the horizon [READ MORE]

Law Firms Watching Actemra Story
Law Firms Watching Actemra Story
September 20, 2017
Denver, CO: Law firms across the US are taking a serious interest in a recent investigative piece of journalism by STAT news published on June 5, 2017 which revealed, “The Food and Drug Administration has received reports on 1,128 people who died after taking Actemra, and has reviewed its safety several times since it was approved. But the agency doesn’t have sophisticated tools to determine whether the drug was a culprit or a bystander in those deaths. [READ MORE]



ADD YOUR COMMENT ON THIS ISSUE

Fields marked * are mandatory. Please read our comment guidelines before posting.

*Name:

Note: Your name will be published with your comment.

*Email Address:

Your email will only be used if a response is needed.

*Your Comment:

Are you the defendant or a subject matter expert on this topic with an opposing viewpoint? We'd love to hear your comments here as well, or if you'd like to contact us for an interview please submit your details here.

Request Dangerous Drugs Legal Help

First name:

Last name:

Email address:

Phone number(s):

Zip/Postal Code:

Defendant:
Describe your complaint:

By submitting this form I agree to the Terms of Service.
There is no cost to submit this form.
I would like to be interviewed by a journalist.
Receive our weekly newsletter with the latest lawsuit news and legal information.


Related Lawsuits

Legal Services:

Advertisement
 
FAQ | TOS | Privacy | Disclaimer | About Us | Contact Us | Press | Advertise | Member Login | Site Map | View Mobile Website

American Bar Association - Proud Member   Better Business Bureau   CAALA   Best of the Web Approved   Public Justice


This work is licensed under a Creative Commons Attribution-NoDerivs 3.0 Unported License © 2001-2017 Online Legal Media. All rights reserved.


Visit other Online Legal Media Websites:

BigClassAction.comCALaborLawNews.com
OnlineLegalMarketing.comHealthEffectsOfAsbestos.com